Cargando…
Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
PURPOSE: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines have been reported to trigger immune side effects. Type 1 diabetes as a manifestation of autoimmune/inflammatory syndrome induced by adjuvants has been reported in a limited number of cases after vaccinations. A few type...
Autores principales: | Aydoğan, Berna İmge, Ünlütürk, Uğur, Cesur, Mustafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282628/ https://www.ncbi.nlm.nih.gov/pubmed/35809159 http://dx.doi.org/10.1007/s12020-022-03130-8 |
Ejemplares similares
-
Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Adipocytokines in Thyroid Dysfunction
por: Aydogan, Berna İmge, et al.
Publicado: (2013) -
Symptomology following mRNA vaccination against SARS-CoV-2
por: Ebinger, Joseph E., et al.
Publicado: (2021) -
Effects of telmisartan and losartan treatments on bone turnover
markers in patients with newly diagnosed stage I hypertension
por: Aydoğan, Berna İ, et al.
Publicado: (2019) -
Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)